Show simple item record

dc.creatorMarathe, Sopan R.
dc.creatorPatil, Amod S.
dc.creatorGanorkar, Saurabh B.
dc.creatorChaudhari, Suraj
dc.creatorShirkhedkar , Atul A.
dc.date2019-10-30
dc.date.accessioned2019-11-13T15:11:56Z
dc.date.available2019-11-13T15:11:56Z
dc.identifierhttp://www.jcchems.com/index.php/JCCHEMS/article/view/1321
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/112781
dc.descriptionIsradipine (ISRA) is a calcium channel blocking agent and a drug of the dihydropyridine (DHP) class. It is utilized for the treatment of hypertension and congestivecardiac failure (CHF). It selectively binds with the calcium channel receptor with high compatibility and averts calcium alteration into cardiac and arterial smoothmuscle cells. ISRA employed to cure deliberate hypertension, used alone or in combination with thiazide diuretics. The present review article represents thecompilation and discussion of analytical methods published in the literature for estimation of ISRA in pharmaceutical samples and biological matrices consisting ofTLC/ densitometry, HPLC, UV-Visible method, Spectrofluorometry, Capillary Electrophoresis (CE), Polarography, Voltammetry and hyphenated techniques suchas LC-MS; LC-MS-MS, GC-MS, etc.en-US
dc.formatapplication/pdf
dc.languageeng
dc.publisherSociedad Chilena de Químicaen-US
dc.relationhttp://www.jcchems.com/index.php/JCCHEMS/article/view/1321/336
dc.sourceJournal of the Chilean Chemical Society; Vol 64 No 3 (2019): Journal of the Chilean Chemical Society; 4565-4570en-US
dc.source0717-9707
dc.source0717-9324
dc.subjectIsradipineen-US
dc.subjecthypertensionen-US
dc.subjectanalytical methodsen-US
dc.subjectbiological samplesen-US
dc.subjectpharmaceutical formulationen-US
dc.titleA BRIEF REVIEW ON ANALYTICAL METHODS FOR ESTIMATION OF ISRADIPINE IN PHARMACEUTICAL FORMULATION AND BIOLOGICAL MATRICESen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


This item appears in the following Collection(s)

Show simple item record